Dashboard
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Net Sales has grown by an annual rate of 6.34% and Operating profit at 12.64% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
HKD 9,640 Million ()
NA (Loss Making)
NA
0.00%
0.51
-999,999.00%
11.81
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2013)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-36.8%
0%
-36.8%
6 Months
-14.29%
0%
-14.29%
1 Year
93.48%
0%
93.48%
2 Years
53.45%
0%
53.45%
3 Years
-40.4%
0%
-40.4%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Lepu Biopharma Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.34%
EBIT Growth (5y)
12.64%
EBIT to Interest (avg)
-2.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
0.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
19.22
EV to EBIT
-6562.55
EV to EBITDA
-7104.01
EV to Capital Employed
13.01
EV to Sales
14764.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.20%
ROE (Latest)
-0.22%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'13 - YoY
Sep'13
Sep'12
Change(%)
Net Sales
0.20
0.00
Operating Profit (PBDIT) excl Other Income
-0.20
-0.10
-100.00%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.50
-0.40
-25.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2013 is 0.00% vs 0.00% in Sep 2012
Consolidated Net Profit
YoY Growth in quarter ended Sep 2013 is -25.00% vs 20.00% in Sep 2012
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
249.00
18.10
1,275.69%
Operating Profit (PBDIT) excl Other Income
-318.70
-606.60
47.46%
Interest
17.70
10.10
75.25%
Exceptional Items
193.30
-113.00
271.06%
Consolidate Net Profit
-33.50
-813.40
95.88%
Operating Profit Margin (Excl OI)
-1,734.80%
-39,629.00%
3,789.42%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 1,275.69% vs 0.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 95.88% vs 34.40% in Dec 2022
About Lepu Biopharma Co., Ltd. 
Lepu Biopharma Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






